发明名称 SUBSTITUTED 1,2,4-TRIAZOLO[3-4-A]PYRIDAZINE
摘要 1. 3-(5-methylisoxazol-3-yl)-6-(1-methyl-1,2,3-triazol-4-yl) methyloxy-1,2,4-triazolo [3,4-a] phthalazine. 2. A pharmaceutical composition comprising the compound as described in Claim 1 and a pharmaceutically acceptable carrier. 3. 3-(5-methylisoxazol-3-yl)-6-(1-methyl-1,2,3-triazol-4-yl) methyloxy-1,2,4-triazolo [3,4-a] phthalazine for use in a method of treatment of the human or animal body. 4. The use of the compound of Claim 1 for the manufacture of a medicament for the enhancement of cognition. 5. A method of enhancing cognition in a subject suffering from diminished cognition, which comprises administering to that subject a cognition enhancing amount of the compound of Claim 1.
申请公布号 EA002824(B1) 申请公布日期 2002.10.31
申请号 EA20000000878 申请日期 1999.02.17
申请人 MERCK AHARP &DOHME LIMITED 发明人 CARLING, WILLIAM, ROBERT;LADDUWAHETTY, TAMARA;MACLEOD, ANGUS, MURRAY;MERCHANT, KEVIN, JOHN;MOORE, KEVIN, WILLIAM;STERNFIELD, FRANCINE;STREET, LESLIE, JOSEPH
分类号 A61K31/5025;A61P25/28;C07D487/04 主分类号 A61K31/5025
代理机构 代理人
主权项
地址